Innovative Product Focus OraChrom specializes in high-performance stationary phases based on Poly (Styrene-divinylbenzene) for chromatography, offering solutions that can reduce costly polishing steps in biopharmaceutical manufacturing, presenting an opportunity to target biopharma companies seeking more efficient purification methods.

Market Positioning Operating in the competitive biotech research industry with established players like Bio-Rad and Waters, OraChrom has the potential to differentiate itself by emphasizing its advanced, non-leaching stationary phases and focus on biopharmaceutical applications.

Growth Potential With revenue ranging from 1 to 10 million dollars and a highly specialized product portfolio, OraChrom is positioned for targeted outreach to mid-sized biopharmaceutical firms looking to optimize purification processes and reduce production costs.

Technology & Innovation Utilizing cutting-edge materials such as Simulated-Monoliths™ stationary phases and emphasizing mechanical and chemical robustness, OraChrom can appeal to manufacturers seeking durable and efficient chromatography solutions, opening opportunities in research and production settings.

Sales Expansion Strategy Given its specialized niche and growth stage, OraChrom can benefit from targeted outreach to biotech firms and contract manufacturing organizations (CMOs) that prioritize innovation in biopharmaceutical purification, expanding its customer base in a rapidly evolving industry.